The U.S. Food and Drug Administration has approved the use of an intravenous form of the pain reliever meloxicam (Anjeso, Baudax Bio) for the relief of moderate to severe pain.
Rheumatology Network Editorial Staff
A study of 312,081 pregnant women with rheumatoid arthritis, spondyloarthritis or no inflammatory arthritis, finds that women with rheumatoid arthritis are more likely to have pregnancy complications.
New this week: The American College of Rheumatology has issued treatment guidelines for the management of reproductive health in rheumatic and musculoskeletal diseases. They include 12 ungraded good practice statements and 131 graded recommendations for all female patients considering becoming pregnant.
In this week's news roundup, we focus on skin cancer rates associated with methotrexate use, skin cancer in psoriasis cases and fatigue associated with arthritis.
A double-blind, placebo-controlled, randomized clinical trial has confirmed that low-dose methotrexate is associated with an increased risk of skin cancer, according to a study published this week in the Annals of Internal Medicine.
A systematic review and meta-analysis published today in JAMA Dermatology confirms that psoriasis patients have a slightly increased risk of cancer, specifically, keratinocyte cancer and lymphomas.
Visceral fat appears to be associated with an increased risk of musculoskeletal and widespread pain, according to researchers writing this week in Arthritis and Rheumatology. Plus, a small study shows promise in a new treatment for a rare form of pediatric lupus. This and more news in today's rheumatology news roundup.
New treatments for rheumatoid arthritis can effectively control inflammation, but they do little to improve quality of life indicators—like fatigue—that are important to patients, shows a new study.
In this slideshow we highlight some key facts about the use of supplements to prevent fracture in women and men over the age of 50. Existing treatment guildelines recommend a combination approach with vitamin D and calcium, but some clinical trials are not entirely in agreement. Learn more in this slideshow.
Regardless of BMI level, having a genetic susceptibility for gout may be a stronger predictor of disease than weight, say researchers writing in Arthritis and Rheumatology this week.